Europe Iodinated contrast media in interventional X-ray Market – Industry Trends and Forecast to 2027

  • Pharmaceutical
  • Published Report
  • Dec 2019
  • Europe
  • 350 Pages
  • No of Tables: 117
  • No of Figures: 41

Europe Iodinated Contrast Media in Interventional X-Ray Market By Route of Administration (Intravenous, Oral, Rectal, Others), Indication (Cardiology, Neurology, General Surgery, Oncology, Urology), Agent Type (Non-Ionic, Ionic), End User (Hospital, Specialty Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Research & Academic Institutes), By Country (Germany, Italy, France, U.K., Spain, Russia, Netherlands, Switzerland, Belgium, Turkey, and Rest of Europe), Market Trends and  Forecast to 2027

Market Analysis and Insights: Europe Iodinated contrast media in interventional X-ray Market

Iodinated contrast media in interventional X-ray market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.9% in the forecast period of 2020 to 2027 and expected to reach USD 886.27 million by 2027 from USD 610.51 million in 2019. Increase in the research and developmental activities of contrast agents and high use of interventional X-ray in various diagnosis applications are the major factors for the market growth.

Iodinated contrast media in interventional X-ray are increasing with increasing demand for diagnosis of chronic diseases. Increasing prevalence of cardiac diseases and growing preference for interventional X-rays technique healthcare over the globe have increased the adoption of diagnostic centers globally. The need for diagnostic imaging has increased resulting to the contribution to the medical costs and also by providing exposure to the ionizing radiation. Moreover, rising incidence of chronic diseases, increasing prevalence of cardiac diseases and rising diagnostic centers across the region led to the growth of iodinated contrast media in interventional X-ray market. The need for diagnostic imaging has increased resulting to the contribution to the medical costs and also by providing exposure to the ionizing radiation.

This iodinated contrast media in interventional X-ray market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Europe Iodinated Contrast Media in Interventional X-Ray Market Scope and Market Size

Iodinated contrast media in interventional X-ray market is segmented on the basis of route of administration, indication, agent type and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Europe Iodinated contrast media in interventional X-ray Market

Based on route of administration, iodinated contrast media in interventional X-ray market is segmented into oral, intravenous, rectal, others. Intravenous segment is dominating the market because it’s most preferred route of administration among interventional radiologist due to their characteristics.

Based on agent type, iodinated contrast media in interventional X-ray market is segmented into ionic and non-ionic. Non-ionic segment is dominating the market as these iodinated contrast agents are mainly used in cardio-interventional diagnostics procedure for enhancing the perfusion in tissues and the blood.

Based on indication, iodinated contrast media in interventional X-ray market is segmented into cardiology, oncology, urology, general surgery and neurology. Cardiology segment is dominating the market due to high use of iodinated contrast media in chronic disease such as cardiovascular disease and other heart disease which requires continuous monitoring through X-rays for treatment.

Based on end user, the market is segmented into hospital, specialty clinics, diagnostic centers, ambulatory surgical centres, research & academic institutes. Hospital segment is dominating the market throughout the forecast period as hospital facilities are first line of treatment place for interventional radiology diagnostic procedure.

Iodinated Contrast Media in Interventional X-Ray Market Country Level Analysis

Europe market is analysed and market size information is provided by country by route of administration, agent type, indication, and end user as referenced above.

The countries covered in the iodinated contrast media in interventional X-ray market report are Germany, Italy, France, U.K., Spain, Russia, Netherlands, Switzerland, Belgium, Turkey, and Rest of Europe in Europe.

Europe iodinated contrast media in interventional X-ray market is growing due to awareness about interventional diagnosis and treatment of the chronic disease is expected to grow at the significant growth rate in the forecast period of 2020 to 2027. Europe iodinated contrast media in interventional X-ray market is growing due to government initiatives to increase the awareness about cancer and cardiac diagnosis, innovative contrast agent products being launched by several companies is expected to grow at the significant growth rate in the forecast period of 2020 to 2027. U.K. is growing with the highest CAGR as this is a developed country and more number of diagnostic companies is present in the country. Additionally, advancements of interventional X-ray technique and presence of leading companies in the region have also generated new prospects for iodinated contrast media in interventional X-ray.

The country section of the iodinated contrast media in interventional X-ray market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, and regulatory scenario and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Rising Prevalence of Chronic Disease and Preference for Preventive Health Check-Ups

Iodinated contrast media in interventional X-ray market also provides you with detailed market analysis for every country growth in installed base of different kind of products for iodinated contrast media in interventional X-ray market, impact of technology using life line curves and changes in automobile regulatory scenarios and their impact on the iodinated contrast media in interventional X-ray market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Iodinated Contrast Media in Interventional X-Ray Market Share Analysis

Iodinated contrast media in interventional X-ray market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to iodinated contrast media in interventional X-ray market.

The major players covered in the report are Bayer AG, Iso-Tex Diagnostics, Inc., Bracco Diagnostic Inc., Novalek Pharmaceuticals Pvt. Ltd., iMAX, Taejoon Pharm, Unijules life science Ltd, General Electric, Guerbet LLC, J.B.Chemicals & Pharmaceuticals Ltd among others players domestic and global. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

For instance,

  • In June 2019, General Electric and Daiichi Sankyo Company did an agreement that Daiichi Sankyo to transfer authorization of marketing rights for four diagnostic imaging agents in Japan to GE Healthcare. After completing this agreement, the company expanded their diagnostic imaging agents in the Japan. This will help company to expand their business in the market.
  • In July 2018, General Electric announced that they have launched ready-to-drink oral solution of iodinated contrast agent which can help physicians improving the visualization of diagnostic abdominal gastrointestinal tract. With this new formulation of contrast agent the company enhanced its choice of options for oral contrast agent which is available to radiologists and patients.

Such investment and partnership other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for iodinated contrast media in interventional X-ray through expanded model range.

Customization Available : Europe Iodinated contrast media in interventional X-ray Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 LIST OF FDA APPROVED NON-IONIC IODINATED AGENTS

TABLE 2 LIST OF FDA APPROVED IONIC IODINATED AGENTS

TABLE 3 COST OF CONTRAST MEDIA

TABLE 4 LIST OF UPCOMING GENERIC CONTRAST MEDIA AGENTS

TABLE 5 DOSAGE OF CONTRAS MEDIA TO BE TAKEN AS PER PATIENT’S WEIGHT

TABLE 6 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 7 EUROPE INTRAVENOUS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 8 EUROPE ORAL IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 9 EUROPE RECTAL IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 10 EUROPE OTHERS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 11 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY END USER, 2018-2027 (USD MILLION)

TABLE 12 EUROPE HOSPITAL IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 13 EUROPE SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 14 EUROPE SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 15 EUROPE DIAGNOSTIC CENTERS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 16 EUROPE AMBULATORY SURGICAL CENTERS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 17 EUROPE RESEARCH & ACADEMIC INSTITUTES IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY INDICATION, 2018-2027 (USD MILLION)

TABLE 19 EUROPE CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 20 EUROPE CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 21 EUROPE NEUROLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 22 EUROPE GENERAL SURGERY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 23 EUROPE ONCOLOGY SURGERY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 24 EUROPE UROLOGY SURGERY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 25 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 26 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (VOLUME IN LITER)

TABLE 27 EUROPE NON-IONIC IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 28 EUROPE IONIC IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 29 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 30 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 31 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 32 EUROPE CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 33 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 34 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 35 EUROPE SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 36 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 37 GERMANY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 38 GERMANY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY INDICATION, 2018-2027 (USD MILLION)

TABLE 39 GERMANY CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 40 GERMANY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 41 GERMANY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 42 GERMANY SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 43 GERMANY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 44 GERMANY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 45 U.K. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 46 U.K. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 47 U.K. CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 48 U.K. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 49 U.K. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 50 U.K. SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 51 U.K. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 52 U.K. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 53 FRANCE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 54 FRANCE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 55 FRANCE CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 56 FRANCE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 57 FRANCE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 58 FRANCE SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 59 FRANCE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 60 FRANCE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 61 ITALY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 62 ITALY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 63 ITALY CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 64 ITALY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 65 ITALY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 66 ITALY SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 67 ITALY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 68 ITALY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 69 SPAIN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 70 SPAIN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 71 SPAIN CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 72 SPAIN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 73 SPAIN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 74 SPAIN SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 75 SPAIN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 76 SPAIN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 77 SWITZERLAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 78 SWITZERLAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 79 SWITZERLAND CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 80 SWITZERLAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 81 SWITZERLAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 82 SWITZERLAND SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 83 SWITZERLAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 84 SWITZERLAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 85 NETHERLANDS IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 86 NETHERLANDS IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 87 NETHERLANDS CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 88 NETHERLANDS IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 89 NETHERLANDS IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 90 NETHERLANDS SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 91 NETHERLANDS IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 92 NETHERLANDS IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 93 RUSSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 94 RUSSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 95 RUSSIA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 96 RUSSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 97 RUSSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 98 RUSSIA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 99 RUSSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 100 RUSSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 101 BELGIUM IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 102 BELGIUM IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 103 BELGIUM CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 104 BELGIUM IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 105 BELGIUM IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 106 BELGIUM SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 107 BELGIUM IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 108 BELGIUM IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 109 TURKEY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 110 TURKEY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 111 TURKEY CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 112 TURKEY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 113 TURKEY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 114 TURKEY SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 115 TURKEY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 116 TURKEY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 117 REST OF EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions